Loading…

Genetic Defects in Postsqualene Cholesterol Biosynthesis

In humans and mice, four different genetic defects in the nine biosynthetic steps from lanosterol to cholesterol have been identified. They impair the activity of a putative C3-sterol dehydrogenase (Nshdl, X-linked dominant bare patches/striated mutation in mice), the sterol Δ8-Δ7 isomerase/EBP (Ebp...

Full description

Saved in:
Bibliographic Details
Published in:Trends in Endocrinology & Metabolism 2000-04, Vol.11 (3), p.106-114
Main Authors: Moebius, Fabian F., Fitzky, Barbara U., Glossmann, Hartmut
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In humans and mice, four different genetic defects in the nine biosynthetic steps from lanosterol to cholesterol have been identified. They impair the activity of a putative C3-sterol dehydrogenase (Nshdl, X-linked dominant bare patches/striated mutation in mice), the sterol Δ8-Δ7 isomerase/EBP (Ebp, X-linked dominant tattered mutation in mice; chondrodysplasia punctata (CDPX2) in humans), the Δ24-sterol reductase (autosomal recessive desmosterolosis) and the Δ7-sterol reductase (DHCR7 gene, autosomal recessive Smith–Lemli–Opitz syndrome in humans). These inborn errors in postsqualene cholesterol metabolism result in dysmorphogenetic syndromes of variable severity. The X-linked dominant mutations result in mosaicism in females, as a result of X-inactivation, and midgestational lethality in males. The mechanisms by which the depletion of cholesterol or the accumulation of intermediates impair morphogenetic programs are unclear. So far, no cellular processes that require an intact cholesterol biosynthetic pathway have been identified, although the morphogenetic hedgehog–patched signaling cascade is a candidate.
ISSN:1043-2760
1879-3061
DOI:10.1016/S1043-2760(00)00235-6